Ordemann, R <br/><br/>
Use of targeted therapy for refractory ALK-positive anaplastic large cell lymphoma as a bridging strategy prior to allogeneic transplantation.  [electronic resource] 

 -  Annals of hematology  Jan 2013 
 - 125-7 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter 
<br/><br/><label>ISSN: </label>1432-0584 
<br/><br/><label>Standard No.: </label>10.1007/s00277-012-1524-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anaplastic Lymphoma Kinase<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Brentuximab Vedotin<br/>Carmustine--administration & dosage<br/>Cisplatin--administration & dosage<br/>Combined Modality Therapy<br/>Compassionate Use Trials<br/>Crizotinib<br/>Cyclophosphamide--administration & dosage<br/>Cytarabine--administration & dosage<br/>Dexamethasone--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Etoposide--administration & dosage<br/>Humans<br/>Immunoconjugates--therapeutic use<br/>Lymphocyte Transfusion<br/>Lymphoma, Large-Cell, Anaplastic--complications<br/>Male<br/>Melphalan--administration & dosage<br/>Molecular Targeted Therapy<br/>Neoplasm Proteins--analysis<br/>Peripheral Blood Stem Cell Transplantation<br/>Prednisone--administration & dosage<br/>Protein Kinase Inhibitors--therapeutic use<br/>Pyrazoles--therapeutic use<br/>Pyridines--therapeutic use<br/>Receptor Protein-Tyrosine Kinases--analysis<br/>Remission Induction<br/>Respiration, Artificial<br/>Respiratory Insufficiency--etiology<br/>Transplantation, Homologous<br/>Vincristine--administration & dosage